Clinical Trial Update: Microbiota Profiling in IBS

View source ↗

Summary

The clinical trial investigating microbiota profiling in irritable bowel syndrome has completed. The sponsor is Wageningen University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Snippet

Sponsor: Wageningen University | Conditions: Irritable Bowel Syndrome, Microbial Colonization | Status: COMPLETED